Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T E Witzig

Showing results (131-140 of 183) with videos related to

Pageof 19
Sort By:
Journal of the National Cancer Institute|December 21, 1994
p53 gene expression in node-positive breast cancer: relationship to DNA ploidy and prognosisJ M Cunningham, J N Ingle, S H Jung, et al.
The American Journal of the Medical Sciences|March 1, 1995
Refractory and relapsing multiple myeloma treated by blood stem cell transplantationM A Gertz, A A Pineda, M G Chen, et al.
British Journal of Haematology|February 15, 2002
Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemiaD F Jelinek, R C Tschumper, S M Geyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd)E Galanis, R Goldberg, J Reid, et al.
Blood Cancer Journal|July 26, 2012
MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterpartsL S Hodge, S F Elsawa, D M Grote, et al.
Leukemia|January 30, 2004
Effect of thalidomide therapy on bone marrow angiogenesis in multiple myelomaS Kumar, T E Witzig, A Dispenzieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trialsT E Witzig, J N Ingle, D J Schaid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Prognostic value of bone marrow angiogenesis in multiple myelomaS V Rajkumar, T Leong, P C Roche, et al.
Blood|April 6, 2001
A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and deathD P Steensma, M A Gertz, P R Greipp, et al.
Bone Marrow Transplantation|June 1, 2004
Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapyS Kumar, M A Gertz, A Dispenzieri, et al.
Pageof 19

Showing results (131-140 of 183) with videos related to

Sort By:
Pageof 19
Journal of the National Cancer Institute|December 21, 1994
p53 gene expression in node-positive breast cancer: relationship to DNA ploidy and prognosisJ M Cunningham, J N Ingle, S H Jung, et al.
The American Journal of the Medical Sciences|March 1, 1995
Refractory and relapsing multiple myeloma treated by blood stem cell transplantationM A Gertz, A A Pineda, M G Chen, et al.
British Journal of Haematology|February 15, 2002
Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemiaD F Jelinek, R C Tschumper, S M Geyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd)E Galanis, R Goldberg, J Reid, et al.
Blood Cancer Journal|July 26, 2012
MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterpartsL S Hodge, S F Elsawa, D M Grote, et al.
Leukemia|January 30, 2004
Effect of thalidomide therapy on bone marrow angiogenesis in multiple myelomaS Kumar, T E Witzig, A Dispenzieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trialsT E Witzig, J N Ingle, D J Schaid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Prognostic value of bone marrow angiogenesis in multiple myelomaS V Rajkumar, T Leong, P C Roche, et al.
Blood|April 6, 2001
A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and deathD P Steensma, M A Gertz, P R Greipp, et al.
Bone Marrow Transplantation|June 1, 2004
Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapyS Kumar, M A Gertz, A Dispenzieri, et al.
Pageof 19